ScholarIQanswers from OpenAlex

Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.

PaperCitations, authors & open-access status

Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. have?

ScholarIQcitation count

Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. has 127 citations in the OpenAlex counts ScholarIQ stores.

When was Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. published?

ScholarIQyear

Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. has 2001 year in the ScholarIQ index.

What is the open-access status of Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.?

ScholarIQoa status

Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. has closed oa status in the ScholarIQ index.

What is the PMID of Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.?

ScholarIQpmid

The PMID for Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. is on the source record.

What is the OpenAlex record for Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.?

ScholarIQopenalex

The OpenAlex for Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial